Medicare Enrolled

Dr. Elizabeth Arvizu, NP

Physician Assistant · San Luis Obispo, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
715 TANK FARM RD STE C, San Luis Obispo, CA 93401
8055435577
In practice since 2009 (16 years)
NPI: 1265661110 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Arvizu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Arvizu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Arvizu

Dr. Elizabeth Arvizu is a physician assistant in San Luis Obispo, CA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Arvizu performed 226 Medicare services across 180 unique beneficiaries.

Between the years covered by Open Payments, Dr. Arvizu received a total of $3,399 from 45 pharmaceutical and/or device companies across 161 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Arvizu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 44% volume in CA $3,399 industry payments

Medicare Practice Summary

Medicare Utilization ↗
226
Medicare services
Top 44% in CA for physician assistant
180
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~14 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
172 $62 $252
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
41 $45 $171
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
13 $42 $189
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,399
Total received (2021-2024)
Avg $850/year across 4 years
Top 9% in CA for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
161
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,299 (97.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$100 (2.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,292
2023
$378
2022
$318
2021
$410

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$379
ABBVIE INC.
$256
AstraZeneca Pharmaceuticals LP
$250
Daiichi Sankyo Inc.
$244
Lilly USA, LLC
$151
Takeda Pharmaceuticals U.S.A., Inc.
$145
GlaxoSmithKline, LLC.
$110
Merck Sharp & Dohme LLC
$92
Exelixis Inc.
$88
Eisai Inc.
$83
Stemline Therapeutics Inc.
$70
SOBI, INC
$70
Novartis Pharmaceuticals Corporation
$58
Celgene Corporation
$51
TAIHO ONCOLOGY, INC.
$27
SERVIER PHARMACEUTICALS LLC
$22
EMD Serono, Inc.
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Astellas Pharma US Inc
$21
Deciphera Pharmaceuticals Inc.
$20
Aveo Pharmaceuticals, Inc.
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$17
Mirati Therapeutics, Inc.
$16
MorphoSys, US Inc.
$16
JAZZ PHARMACEUTICALS INC.
$15
Genentech USA, Inc.
$15
Incyte Corporation
$14
Top 3 companies account for 38.6% of 2024 payments
All-time payments by company (2021-2024) ›
Janssen Biotech, Inc.
$546
Daiichi Sankyo Inc.
$326
AstraZeneca Pharmaceuticals LP
$293
ABBVIE INC.
$256
Lilly USA, LLC
$203
Takeda Pharmaceuticals U.S.A., Inc.
$168
GlaxoSmithKline, LLC.
$151
Eisai Inc.
$139
Merck Sharp & Dohme LLC
$92
Stemline Therapeutics Inc.
$90
Exelixis Inc.
$88
Novartis Pharmaceuticals Corporation
$79
SOBI, INC
$70
Pharmacyclics LLC, An AbbVie Company
$69
PFIZER INC.
$57
Pharmacyclics LLC, an AbbVie Company
$55
Celgene Corporation
$51
Astellas Pharma US Inc
$44
E.R. Squibb & Sons, L.L.C.
$41
Boehringer Ingelheim Pharmaceuticals, Inc.
$37
EISAI INC.
$35
ADC Therapeutics America, Inc.
$34
Genentech USA, Inc.
$31
Amgen Inc.
$30
Mirati Therapeutics, Inc.
$30
Incyte Corporation
$30
TAIHO ONCOLOGY, INC.
$27
Myovant Sciences Inc.
$26
Ipsen Biopharmaceuticals, Inc
$24
SERVIER PHARMACEUTICALS LLC
$22
EMD Serono, Inc.
$22
Deciphera Pharmaceuticals Inc.
$20
Aveo Pharmaceuticals, Inc.
$19
Bayer HealthCare Pharmaceuticals Inc.
$18
Merck Sharp & Dohme Corporation
$18
Seagen Inc.
$18
GENZYME CORPORATION
$18
SUN PHARMACEUTICAL INDUSTRIES INC.
$17
Gilead Sciences, Inc.
$16
MorphoSys, US Inc.
$16
JAZZ PHARMACEUTICALS INC.
$15
Dendreon Pharmaceuticals LLC
$15
Taiho Oncology, Inc.
$15
PUMA BIOTECHNOLOGY, INC.
$14
Shield Therapeutics Inc
$14
Top 3 companies account for 34.3% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ALUNBRIG · BOSULIF · CABOMETYX · CALQUENCE · CARVYKTI · CYRAMZA · DARZALEX · DOPTELET · ENHERTU · EPKINLY · Enhertu · FOTIVDA · FRUZAQLA · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · JAYPIRCA · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · NERLYNX · OJJAARA · ONIVYDE · OPDIVO · ORGOVYX · Orserdu · PROVENGE · Padcev · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Stivarga · TAGRISSO · TECVAYLI · TUKYSA · Tibsovo · Trodelvy · VENCLEXTA · VERZENIO · Vanflyta · Venclexta · Xtandi · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for physician assistant in CA.

Looking for a physician assistant in San Luis Obispo?
Compare physician assistants in the San Luis Obispo area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician assistants within 10 mi
42
Per 100K population
14.9
County median income
$93,398
Nearest hospital
FRENCH HOSPITAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Arvizu is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 9% of CA peers, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Arvizu experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Arvizu performed 172 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Arvizu receive payments from pharmaceutical companies?
Yes. Dr. Arvizu received a total of $3,399 from 45 companies across 161 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Arvizu's costs compare to other physician assistants in San Luis Obispo?
Dr. Arvizu's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Arvizu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →